Disease Information

Hospital Resources

Bench to Bedside

Michael B. Kastan, MD, PhD
Scientists at St. Jude have shown that it might be possible to make tumor cells more sensitive to irradiation and some types of chemotherapy by treating them with a drug that cripples their ability to repair DNA damage caused by these therapies.
 

Clinical Science

Our mission - to find cures for children with catastrophic diseases through research and treatment - is a constant driving force. It is through the pursuit of that mission that we seize every opportunity to help the children who come to us for care and, in so doing, to create new knowledge that will help children throughout the world.

Why refer a patient to St. Jude for treatment?

Read More

 

The Research Behind the Cures

John T. Sandlund, MD

Drug combination for non-Hodgkin lymphoma produces fewer side effects

A new combination of anti-cancer drugs, when integrated into an existing treatment for non-Hodgkin lymphoma, causes reduced risk for side effects in children than the conventional regimen.

Read More

Scientific Report 2008

Scientific Report

Key research activities and publications by the investigators at St. Jude during 2007 are summarized in the Scientific Report 2008.